IL124499A - ACYLATED ENOL DERIVATIVES OF alpha-KETOESTERS AND alpha-KETOAMIDES - Google Patents

ACYLATED ENOL DERIVATIVES OF alpha-KETOESTERS AND alpha-KETOAMIDES

Info

Publication number
IL124499A
IL124499A IL12449996A IL12449996A IL124499A IL 124499 A IL124499 A IL 124499A IL 12449996 A IL12449996 A IL 12449996A IL 12449996 A IL12449996 A IL 12449996A IL 124499 A IL124499 A IL 124499A
Authority
IL
Israel
Prior art keywords
alpha
ketoamides
ketoesters
enol derivatives
acylated enol
Prior art date
Application number
IL12449996A
Other languages
English (en)
Other versions
IL124499A0 (en
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of IL124499A0 publication Critical patent/IL124499A0/xx
Publication of IL124499A publication Critical patent/IL124499A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12449996A 1995-12-01 1996-11-04 ACYLATED ENOL DERIVATIVES OF alpha-KETOESTERS AND alpha-KETOAMIDES IL124499A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56619695A 1995-12-01 1995-12-01
PCT/US1996/017752 WO1997020856A1 (en) 1995-12-01 1996-11-04 ACYLATED ENOL DERIVATIVES OF α-KETOESTERS AND α-KETOAMIDES

Publications (2)

Publication Number Publication Date
IL124499A0 IL124499A0 (en) 1998-12-06
IL124499A true IL124499A (en) 2003-05-29

Family

ID=24261904

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12449996A IL124499A (en) 1995-12-01 1996-11-04 ACYLATED ENOL DERIVATIVES OF alpha-KETOESTERS AND alpha-KETOAMIDES

Country Status (20)

Country Link
EP (1) EP0863915B1 (xx)
JP (1) JP2000502073A (xx)
KR (1) KR19990071822A (xx)
CN (1) CN1127512C (xx)
AR (1) AR005240A1 (xx)
AT (1) ATE189457T1 (xx)
AU (1) AU705819B2 (xx)
CA (1) CA2239159C (xx)
DE (1) DE69606552T2 (xx)
ES (1) ES2144788T3 (xx)
GR (1) GR3033205T3 (xx)
HU (1) HUP9902417A3 (xx)
IL (1) IL124499A (xx)
MX (1) MX9804265A (xx)
NO (1) NO982467L (xx)
NZ (1) NZ322731A (xx)
PT (1) PT863915E (xx)
TW (1) TW419482B (xx)
WO (1) WO1997020856A1 (xx)
ZA (1) ZA969889B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998001133A1 (fr) * 1996-07-08 1998-01-15 Yamanouchi Pharmaceutical Co., Ltd. Inhibiteurs de la resorption osseuse
ES2221227T3 (es) * 1997-11-24 2004-12-16 MERCK & CO., INC. Derivados sustituidos de beta-alanina como inhibidores de la adhesion celular.
US6645939B1 (en) 1997-11-24 2003-11-11 Merck & Co., Inc. Substituted β-alanine derivatives as cell adhesion inhibitors
WO2006113942A2 (en) * 2005-04-20 2006-10-26 Schering Corporation Method of inhibiting cathepsin activity
KR101012313B1 (ko) * 2008-06-10 2011-02-09 서울대학교산학협력단 염증질환 치료제

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378457A (en) * 1981-12-24 1995-01-03 Virogenetics Corporation Interferon sensitive recombinant poxvirus vaccine
EP0564561A4 (en) * 1990-12-28 1994-08-10 Georgia Tech Res Inst Peptides ketoamides, ketoacids, and ketoesters

Also Published As

Publication number Publication date
AU705819B2 (en) 1999-06-03
DE69606552T2 (de) 2000-09-14
ATE189457T1 (de) 2000-02-15
GR3033205T3 (en) 2000-08-31
KR19990071822A (ko) 1999-09-27
CN1203602A (zh) 1998-12-30
AR005240A1 (es) 1999-04-28
IL124499A0 (en) 1998-12-06
NO982467D0 (no) 1998-05-29
DE69606552D1 (de) 2000-03-09
MX9804265A (es) 1998-09-30
ES2144788T3 (es) 2000-06-16
HUP9902417A2 (hu) 1999-11-29
NZ322731A (en) 1999-10-28
CA2239159A1 (en) 1997-06-12
EP0863915B1 (en) 2000-02-02
WO1997020856A1 (en) 1997-06-12
AU7669796A (en) 1997-06-27
NO982467L (no) 1998-08-03
PT863915E (pt) 2000-05-31
ZA969889B (en) 1997-06-17
JP2000502073A (ja) 2000-02-22
TW419482B (en) 2001-01-21
EP0863915A1 (en) 1998-09-16
HUP9902417A3 (en) 2000-11-28
CN1127512C (zh) 2003-11-12
CA2239159C (en) 2002-09-10

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
EP0863748A4 (en) LIPOSOMAL COMPOSITIONS AND METHODS OF USE
PL323066A1 (en) Derivatives of quinazoline
PL313541A1 (en) Derivatives of quinazoline
PL311736A1 (en) Derivatives of 1h-imidazoles
ZA955759B (en) Acyl derivatives of azolones
IL124938A0 (en) Lactone derivatives of 17-beta-carboxy -carbothio and amide androstane derivatives
GB9525111D0 (en) Glass and glass products
AU5379296A (en) Production of rhein and rhein derivatives
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
GB9526560D0 (en) Use of 2-Amino-Heterocycles
PL318279A1 (en) Substituted derivatives of camptotecin and method of obtaining them
NZ300198A (en) Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines
GB9624745D0 (en) Ornamental structure of product
EP0747051A3 (en) Methods for induction of BEF-1 transcription factor
GB2267529B (en) Doors and methods of forming doors
AU6284596A (en) Production of mono-n-alkyl-dinitroalkylanilines and n-alkyl-dinitroaniline derivatives
ZA96725B (en) Use of phenyclyclohexylcarboxamides
IL124499A (en) ACYLATED ENOL DERIVATIVES OF alpha-KETOESTERS AND alpha-KETOAMIDES
GB9525918D0 (en) Structure of armrest-driven wheelchair
IL113228A (en) Derivatives of anandamide
ZA969429B (en) Amidinohydrazones of ketones
GB2289708B (en) Doors and Methods of Forming Doors
HUT76555A (en) Derivatives of trans apovincaminic-acid-esters
PL312146A1 (en) Novel acylated pseudopetides with thrifluoromethy-substituted 2-azabicyclooctane, method of obtaining and therapeutic agents containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees